RxDoctor Payments Data

Nicholas Kotch, DO

Clinical Cardiac Electrophysiology · St Petersburg, FLNPI 1588942650

Payments from drug & device makers

$37,229in general payments, 2019–2025

Across 662 payments — averaging $56.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik Inc.$14K
  • Medtronic$9K
  • Abbott$4K
  • Biosense Webster, Inc.$3K
  • Boston Scientific$2K
  • Atricure, Inc.$1K
  • plus $4K from 28 others

What the payments were for

  • Travel & lodging$12,95335%
  • Food & beverage$24,19465%
  • Education$820%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,229 in reported general payments places this provider in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida

Medicare billing

Part B allowed, 2024
$158,102
Medicare patients
322
Services billed
1,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban95$94,058
XareltoRivaroxaban28$21,677
Diltiazem 12hr ErDiltiazem Hcl27$2,976
Dofetilide16$2,130
Amiodarone Hcl29$1,739
Metoprolol Succinate49$568
Flecainide Acetate18$409
Digoxin13$317
Propranolol Hcl13$302
ClopidogrelClopidogrel Bisulfate19$265
Fludrocortisone Acetate13$212
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$191
Metoprolol Tartrate26$157
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$77
Furosemide18$68

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$154$94,05895 claims
Johnson & JohnsonXarelto$62$21,67728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.

Other clinical cardiac electrophysiology in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →